Zephase Therapeutics Private Limited
About Zephase Therapeutics Private Limited
Data last updated:
Zephase Therapeutics Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Dr. Reddys Institute Of Life Sciences. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the research and development sector. It was incorporated on 09 May 2011.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2011PTC074375.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Kiranam Chatti and Pushkar Kulkarni.
Its last annual general meeting (AGM) was held on 27 April 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at Survey No. 25 Part – 1 – 9 Ils Building University Of Hyderabad Campus Gachibow, Li, Telangana, India – 500046.
As per the financials filed for FY 2016, the company reported a revenue of ₹91,890, a decline of 66% compared to the previous year. For the same year it recorded a net loss of ₹10,469 (net margin -11.4%) and EBITDA of ₹41,999 (EBITDA margin 45.7%).
CIN History of Zephase Therapeutics Private Limited
Zephase Therapeutics has one previous CIN (Corporate Identification Number): U73100AP2011PTC074375. The current CIN is U73100TG2011PTC074375, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2011PTC074375 | Current |
| U73100AP2011PTC074375 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSurvey No. 25 Part – 1 – 9 Ils Building University Of Hyderabad Campus Gachibow, Li, Telangana, India – 500046
- IndustryResearch & Development, Research & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Zephase Therapeutics Private Limited
The main business activity of Zephase Therapeutics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Zephase Therapeutics Private Limited FY 2016 filings available
Zephase Therapeutics Private Limited reported revenue of ₹91,890 (down 66% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR) of Zephase Therapeutics Private Limited
Revenue fell 66% in the latest year. EBITDA fell 29% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Zephase Therapeutics Private Limited
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹41,999 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹10,469 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Zephase Therapeutics Private Limited
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 45.7% | •••• |
| Net Profit Margin | -11.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Zephase Therapeutics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Zephase Therapeutics Private Limited
Zephase Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiranam Chatti | Director | 09 May 2011 | 15 Years 5 Months | As last reported |
| Pushkar Kulkarni | Director | 09 May 2011 | 15 Years 5 Months | As last reported |
Peer Comparison of Zephase Therapeutics Private Limited
Zephase Therapeutics Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Scientific research and development). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sai Biosystems Private Limited | ₹94,322 (FY 2025) | •••• | •••• | -76.0% | •••• | Nagpur, Maharashtra, India |
| R2e Technologies Private Limited | ₹94,138 (FY 2025) | •••• | •••• | -90.0% | •••• | Kotdwar, Uttarakhand, India |
| Novelgenix Therapeutics Private Limited | ₹93,183 (FY 2025) | •••• | •••• | -98.0% | •••• | Ahmedabad, Gujarat, India |
| Mayurika Trexim Pvt Ltd | ₹93,051 (FY 2025) | •••• | •••• | 37.0% | •••• | Kolkata, West Bengal, India |
| Spitze Aerospace Private Limited | ₹92,500 (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Zephase Therapeutics Private Limited this company | ₹91,890 (FY 2016) | •••• | •••• | -66.0% | •••• | Hyderabad, Telangana, India |
| Indro Robotech Private Limited | ₹90,524 (FY 2022) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Asutosh Raj Vishvaguru Foundation | ₹89,200 (FY 2025) | •••• | •••• | 120.0% | •••• | Agra, Uttar Pradesh, India |
| Techdawn Innovations Private Limited | ₹89,100 (FY 2025) | •••• | •••• | 791.0% | •••• | Kolhapur, Maharashtra, India |
| Iac Krishitech Private Limited | ₹86,512 (FY 2025) | •••• | •••• | -89.0% | •••• | Coimbatore, Tamil Nadu, India |
| Sentro Technology Private Limited | ₹86,474 (FY 2025) | •••• | •••• | 74.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Zephase Therapeutics by revenue in the same principal business activity (Scientific research and development), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Zephase Therapeutics Private Limited
Zephase Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Zephase Therapeutics Private Limited
Employment history and EPFO contributions of people linked to Zephase Therapeutics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Zephase Therapeutics Private Limited
Zephase Therapeutics Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Randall Theodore Peterson ceased to be Director on 30 Mar 2016.
Credit Ratings, Litigation & Regulatory Alerts for Zephase Therapeutics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Zephase Therapeutics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Zephase Therapeutics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Zephase Therapeutics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Zephase Therapeutics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zephase Therapeutics Private Limited
Zephase Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Zephase Therapeutics was a private limited company based in Hyderabad, Telangana, India. The company worked in the research and development industry. It was incorporated on 09 May 2011 and is registered under CIN U73100TG2011PTC074375. The company has been struck off by the Registrar of Companies and is no longer operational.
Zephase Therapeutics had 2 directors:
- Kiranam Chatti - Director
- Pushkar Kulkarni - Director
The CIN (Corporate Identification Number) of Zephase Therapeutics is U73100TG2011PTC074375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Zephase Therapeutics is at Survey No. 25 Part – 1 – 9 Ils Building University Of Hyderabad Campus Gachibow, Li, Telangana, India – 500046.
Zephase Therapeutics was incorporated on 09 May 2011. It is registered with the Registrar of Companies, Hyderabad.
Zephase Therapeutics reported revenue of ₹91,890 for FY 2016 (down 66% YoY).
Zephase Therapeutics has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Zephase Therapeutics reported a net loss of ₹10,469 (net margin -11.4%) and EBITDA of ₹41,999 (EBITDA margin 45.7%) for FY 2016, as per its filed financial statements.
Zephase Therapeutics operated in the research and development industry. It worked in this industry before it was struck off.
No. Zephase Therapeutics is not listed on any stock exchange. It is an unlisted company.